<DOC>
	<DOCNO>NCT00417326</DOCNO>
	<brief_summary>The purpose study determine safety efficacy ONO-5046Na patient acute respiratory failure associate community-acquired pneumonia</brief_summary>
	<brief_title>Controlled Study ONO-5046Na Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Sivelestat</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Patients communityacquired pneumonia Patients acute respiratory failure Patients nosocomial pneumonia Patients mechanical ventilation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-5046Na</keyword>
	<keyword>acute respiratory failure</keyword>
	<keyword>community-acquired pneumonia</keyword>
</DOC>